Diabetes Care, Vol 22, Issue 7 1125-1136, Copyright © 1999 by American Diabetes Association

ARTICLES

Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group

OBJECTIVE: To determine in patients with type 2 diabetes the effects on quality of life (QOL) of therapies for improving blood glucose control and for improving blood pressure (BP) control, diabetic complications, and hypoglycemic episodes. RESEARCH DESIGN AND METHODS: We performed two cross-sectional studies of patients enrolled in randomized controlled trials of 1) an intensive blood glucose control policy compared with a conventional blood glucose control policy, and 2) a tight BP control policy compared with a less tight BP control policy. Also undertaken was a longitudinal study of patients in a randomized controlled trial of an intensive blood glucose control policy compared with a conventional blood glucose control policy. Subjects' QOL was assessed before or at the time of randomization and from 6 months to 6 years after randomization. Two cross-sectional samples of type 2 diabetic patients were randomized to therapies for blood glucose control: 1) 2,431 patients, mean age 60, duration from randomization 8.0 years, completed a "specific" questionnaire covering four aspects of QOL, and 2) 3,104 patients, mean age 62, duration from randomization 11 years, completed a "generic" QOL measure. Of these samples, 628 and 747 patients, respectively, were also randomized to therapies for BP control. A sample of 122 non-diabetic control subjects, average age 62, were also given the specific questionnaire. A longitudinal sample of 374 type 2 diabetic patients randomized to either intensive or conventional blood glucose policies, mean age at randomization 52, were given the specific questionnaire. Sample-sizes at 6 months and 1, 2, 3, 4, 5, and 6 years after randomization were 322, 307, 280, 253, 225, 163, and 184, respectively. The specific questionnaire assessed specific domains of QOL, including mood disturbance (Profile of Mood State), cognitive mistakes (Cognitive Failures Questionnaire), symptoms, and work satisfaction; the generic questionnaire (EQ5D) assessed general health. Both questionnaires were self-administered. RESULTS: The cross-sectional studies showed that allocated therapies were neutral in effect, with neither improvement nor deterioration in QOL scores for mood, cognitive mistakes, symptoms, work satisfaction, or general health. The longitudinal study also showed no difference in QOL scores for the specific domains assessed, other than showing marginally more symptoms in patients allocated to conventional than to intensive policy. In the cross-sectional studies, patients who had had a macrovascular complication in the last year had worse general health, as measured by the generic questionnaire, than those without complications, with scale scores median 60 and 78 respectively (P = 0.0006) and tariff scores median 0.73 and 0.83 respectively (P = 0.0012); more problems with mobility, 64 and 36%, respectively (P < 0.0001); and more problems with usual activities, 48 and 28% respectively (P = 0.0023). As measured by the specific questionnaire, they also showed reduced vigor (P = 0.0077). Patients who had had a microvascular complication in the last year reported more tension (P = 0.0082) and total mood disturbance (P = 0.0054), as measured by the specific questionnaire, than patients without complications. Patients treated with insulin who had had two or more hypoglycemic episodes during the previous year reported more tension (P = 0.0023), more overall mood disturbance (P = 0.0009), and less work satisfaction (P = 0.0042), as measured by the specific questionnaire, than those with no hypoglycemic attacks, after adjusting for age, duration from randomization, systolic BP, HbA1c, and sex in a multivariate polychotomous regression. CONCLUSIONS: In patients with type 2 diabetes, complications of the disease affected QOL, whereas therapeutic policies shown to reduce the risk of complications had no effect on QOL. It cannot be discerned whether frequent hypoglycemic episodes affect QOL, or whether patients with certain p
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				G. S. Magwood, J. Zapka, and C. Jenkins A Review of Systematic Reviews Evaluating Diabetes Interventions: Focus on Quality of Life and Disparities The Diabetes Educator, March 1, 2008; 34(2): 242 - 265. [Abstract] [Full Text] [PDF]

				J. B. Dixon, P. E. O'Brien, J. Playfair, L. Chapman, L. M. Schachter, S. Skinner, J. Proietto, M. Bailey, and M. Anderson Adjustable Gastric Banding and Conventional Therapy for Type 2 Diabetes: A Randomized Controlled Trial JAMA, January 23, 2008; 299(3): 316 - 323. [Abstract] [Full Text] [PDF]

				E. S. Huang, S. E.S. Brown, B. G. Ewigman, E. C. Foley, and D. O. Meltzer Patient Perceptions of Quality of Life With Diabetes-Related Complications and Treatments Diabetes Care, October 1, 2007; 30(10): 2478 - 2483. [Abstract] [Full Text] [PDF]

				C. Li, E. S. Ford, A. H. Mokdad, R. Jiles, and W. H. Giles Clustering of Multiple Healthy Lifestyle Habits and Health-Related Quality of Life Among U.S. Adults With Diabetes Diabetes Care, July 1, 2007; 30(7): 1770 - 1776. [Abstract] [Full Text] [PDF]

				A. I. Vinik and Q. Zhang Adding Insulin Glargine Versus Rosiglitazone: Health-related quality-of-life impact in type 2 diabetes Diabetes Care, April 1, 2007; 30(4): 795 - 800. [Abstract] [Full Text] [PDF]

				D. J. Wexler Low risk of depression in diabetes? Would that it were so. Can. Med. Assoc. J., July 4, 2006; 175(1): 47 - 47. [Full Text] [PDF]

				R. Nakahara, K. Yoshiuchi, H. Kumano, Y. Hara, H. Suematsu, and T. Kuboki Prospective Study on Influence of Psychosocial Factors on Glycemic Control in Japanese Patients With Type 2 Diabetes Psychosomatics, June 1, 2006; 47(3): 240 - 246. [Abstract] [Full Text] [PDF]

				D. A. Chyun, G. D. Melkus, D. M. Katten, W. J. Price, J. A. Davey, N. Grey, G. Heller, and F. J. Th. Wackers The association of psychological factors, physical activity, neuropathy, and quality of life in type 2 diabetes. Biol Res Nurs, April 1, 2006; 7(4): 279 - 288. [Abstract] [PDF]

				J. Bottomley, A. J Palmer, R. Williams, J. Dormandy, and M. Massi-Benedetti Review: PROactive 03: Pioglitazone, type 2 diabetes and reducing macrovascular events -- economic implications? The British Journal of Diabetes & Vascular Disease, March 1, 2006; 6(2): 63 - 70. [Abstract] [PDF]

				E. S. Huang, M. Shook, L. Jin, M. H. Chin, and D. O. Meltzer The Impact of Patient Preferences on the Cost-Effectiveness of Intensive Glucose Control in Older Patients With New-Onset Diabetes Diabetes Care, February 1, 2006; 29(2): 259 - 264. [Abstract] [Full Text] [PDF]

				W. Hardeman, S. Sutton, S. Griffin, M. Johnston, A. White, N. J. Wareham, and A. L. Kinmonth A causal modelling approach to the development of theory-based behaviour change programmes for trial evaluation Health Educ. Res., December 1, 2005; 20(6): 676 - 687. [Abstract] [Full Text] [PDF]

				J. B. Dixon, W. J. Pories, P. E. O'Brien, P. R. Schauer, and P. Zimmet Surgery as an Effective Early Intervention for Diabesity: Why the reluctance? Diabetes Care, February 1, 2005; 28(2): 472 - 474. [Full Text] [PDF]

				T. Hammerschmidt, H.-P. Zeitler, M. Gulich, and R. Leidl A Comparison of Different Strategies to Collect Standard Gamble Utilities Med Decis Making, October 1, 2004; 24(5): 493 - 503. [Abstract] [PDF]

				J. Gilbert, J. Raboud, and B. Zinman Meta-Analysis of the Effect of Diabetes on Restenosis Rates Among Patients Receiving Coronary Angioplasty Stenting Diabetes Care, April 1, 2004; 27(4): 990 - 994. [Abstract] [Full Text] [PDF]

				M. M. Funnell, D. F. Kruger, and M. Spencer Self-Management Support for Insulin Therapy in Type 2 Diabetes The Diabetes Educator, March 1, 2004; 30(2): 274 - 280. [PDF]

				D. N. Firestone, L. Jimenez-Briceno, J. O. Reimann, G. A. Talavera, W. H. Polonsky, and S. V. Edelman Predictors of Diabetes-Specific Knowledge and Treatment Satisfaction Among Costa Ricans The Diabetes Educator, March 1, 2004; 30(2): 281 - 292. [PDF]

				T. E. Burroughs, R. Desikan, B. M. Waterman, D. Gilin, and J. McGill Development and Validation of the Diabetes Quality of Life Brief Clinical Inventory Diabetes Spectr, January 1, 2004; 17(1): 41 - 49. [Abstract] [Full Text] [PDF]

				S. L. Maddigan, D. H. Feeny, and J. A. Johnson A Comparison of the Health Utilities Indices Mark 2 and Mark 3 in Type 2 Diabetes Med Decis Making, November 1, 2003; 23(6): 489 - 501. [Abstract] [PDF]

				A. Fritsche, M. A. Schweitzer, H.-U. Haring, and the 4001 Study Group* Glimepiride Combined with Morning Insulin Glargine, Bedtime Neutral Protamine Hagedorn Insulin, or Bedtime Insulin Glargine in Patients with Type 2 Diabetes: A Randomized, Controlled Trial Ann Intern Med, June 17, 2003; 138(12): 952 - 959. [Abstract] [Full Text] [PDF]

				J. B. Meigs, E. Cagliero, A. Dubey, P. Murphy-Sheehy, C. Gildesgame, H. Chueh, M. J. Barry, D. E. Singer, and D. M. Nathan A Controlled Trial of Web-Based Diabetes Disease Management: The MGH Diabetes Primary Care Improvement Project Diabetes Care, March 1, 2003; 26(3): 750 - 757. [Abstract] [Full Text] [PDF]

				R. Harris, K. Donahue, S. S. Rathore, P. Frame, S. H. Woolf, and K. N. Lohr Screening Adults for Type 2 Diabetes: A Review of the Evidence for the U.S. Preventive Services Task Force Ann Intern Med, February 4, 2003; 138(3): 215 - 229. [Abstract] [Full Text] [PDF]

				J. T. Coffey, M. Brandle, H. Zhou, D. Marriott, R. Burke, B. P. Tabaei, M. M. Engelgau, R. M. Kaplan, and W. H. Herman Valuing Health-Related Quality of Life in Diabetes Diabetes Care, December 1, 2002; 25(12): 2238 - 2243. [Abstract] [Full Text] [PDF]

				J. C. Zgibor and D. Simmons Barriers to Blood Glucose Monitoring in a Multiethnic Community Diabetes Care, October 1, 2002; 25(10): 1772 - 1777. [Abstract] [Full Text] [PDF]

				J. Speight Assessing the Impact of Diabetes Screening on Quality of Life or Quality of Health?: Semantics are important Diabetes Care, October 1, 2002; 25(10): 1893 - 1894. [Full Text]

				C. A Reasner and B. Goke Overcoming the barriers to effective glycaemic control for type 2 diabetes The British Journal of Diabetes & Vascular Disease, July 1, 2002; 2(4): 290 - 295. [PDF]

				D. Edelman, M. K. Olsen, T. K. Dudley, A. C. Harris, and E. Z. Oddone Impact of Diabetes Screening on Quality of Life Diabetes Care, June 1, 2002; 25(6): 1022 - 1026. [Abstract] [Full Text] [PDF]

				W. K. Redekop, M. A. Koopmanschap, R. P. Stolk, G. E.H.M. Rutten, B. H.R. Wolffenbuttel, and L. W. Niessen Health-Related Quality of Life and Treatment Satisfaction in Dutch Patients With Type 2 Diabetes Diabetes Care, March 1, 2002; 25(3): 458 - 463. [Abstract] [Full Text] [PDF]

				J. B. Dixon and P. E. O'Brien Health Outcomes of Severely Obese Type 2 Diabetic Subjects 1 Year After Laparoscopic Adjustable Gastric Banding Diabetes Care, February 1, 2002; 25(2): 358 - 363. [Abstract] [Full Text] [PDF]

				M. Rose, H. Fliege, M. Hildebrandt, T. Schirop, and B. F. Klapp The Network of Psychological Variables in Patients With Diabetes and Their Importance for Quality of Life and Metabolic Control Diabetes Care, January 1, 2002; 25(1): 35 - 42. [Abstract] [Full Text] [PDF]

				N. d. F. Olivarius, H. Beck-Nielsen, A. H. Andreasen, M. Horder, and P. A Pedersen Randomised controlled trial of structured personal care of type 2 diabetes mellitus BMJ, October 27, 2001; 323(7319): 970 - 970. [Abstract] [Full Text] [PDF]

				M. Burden and A.C. Burden Blood Pressure and the U.K. Prospective Diabetes Study Diabetes Spectr, October 1, 2001; 14(4): 235 - 240. [Abstract] [Full Text] [PDF]

				C. D. Miller, L. S. Phillips, D. C. Ziemer, D. L. Gallina, C. B. Cook, and I. M. El-Kebbi Hypoglycemia in Patients With Type 2 Diabetes Mellitus Arch Intern Med, July 9, 2001; 161(13): 1653 - 1659. [Abstract] [Full Text] [PDF]

				M. J. Franz, J. G. Pastors, H. Warshaw, and A. E. Daly Does "Diet" Fail? The Diabetes Educator, July 1, 2001; 27(4): 563 - 570. [PDF]

				J. H. Scarpello Review: Optimal dosing strategies for maximising the clinical response to metformin in type 2 diabetes The British Journal of Diabetes & Vascular Disease, January 1, 2001; 1(1): 28 - 36. [Abstract] [PDF]

				A. Gray, M. Raikou, A. McGuire, P. Fenn, R. Stevens, C. Cull, I. Stratton, A. Adler, R. Holman, and R. Turner Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41) BMJ, May 20, 2000; 320(7246): 1373 - 1378. [Abstract] [Full Text]

				R. E. Glasgow Outcomes of and for Diabetes Education Research The Diabetes Educator, November 1, 1999; 25(6_suppl): 74 - 88. [Abstract] [PDF]